VERTEX GENETIC THERAPIES Trademark
Trademark Overview
On Wednesday, August 14, 2019, a trademark application was filed for VERTEX GENETIC THERAPIES with the United States Patent and Trademark Office. The USPTO has given the VERTEX GENETIC THERAPIES trademark a serial number of 88578476. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, June 7, 2020. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VERTEX GENETIC THERAPIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
house mark for pharmaceutical preparations; nucleic acid medicines; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy
medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
General Information
| Serial Number | 88578476 |
| Word Mark | VERTEX GENETIC THERAPIES |
| Filing Date | Wednesday, August 14, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Sunday, June 7, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | house mark for pharmaceutical preparations; nucleic acid medicines; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy |
| Goods and Services | medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 29, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 29, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vertex Pharmaceuticals Incorporated |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
Trademark Events
| Event Date | Event Description |
| Monday, June 8, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Sunday, June 7, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, February 10, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, November 20, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 20, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 20, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, November 14, 2019 | ASSIGNED TO EXAMINER |
| Thursday, August 29, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, August 17, 2019 | NEW APPLICATION ENTERED IN TRAM |
